Finasteride and RU-58841 Interaction
Finasteride and RU-58841 have a compatible interaction with 90% confidence. Different mechanisms of action. RU-58841 is a topical androgen receptor antagonist, while finasteride reduces DHT production systemically. Some users combine them for a multi-target approach to hair loss, though RU-58841 lacks FDA approval. Both compounds affect the skin, so monitoring these systems is recommended.
Compound Profiles
Finasteride
5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH
Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).
View full profileRU-58841
Topical Anti-Androgen | Experimental Hair Loss Treatment
RU-58841 functions as a competitive antagonist of the androgen receptor (AR). When applied topically to the scalp, it penetrates the skin and binds directly to androgen receptors in dermal papilla cells of hair follicles, preventing dihydrotestosterone (DHT) and testosterone from activating those receptors.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Finasteride with RU-58841?
Yes, Finasteride and RU-58841 can generally be taken together. Different mechanisms of action. RU-58841 is a topical androgen receptor antagonist, while finasteride reduces DHT production systemically. Some users combine them for a multi-target approach to hair loss, though RU-58841 lacks FDA approval.
Is Finasteride and RU-58841 safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Finasteride and RU-58841?
Different mechanisms of action. RU-58841 is a topical androgen receptor antagonist, while finasteride reduces DHT production systemically. Some users combine them for a multi-target approach to hair loss, though RU-58841 lacks FDA approval. This assessment has 90% confidence and is based on documented research data.
How should I time Finasteride and RU-58841?
Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and RU-58841 has a half-life of ~1 hour topically (very short systemic half-life). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.